Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD-OS in Developmental and Epileptic Encephalopathy (DEE)
NCT07723976Phase 3Not yet recruiting
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Oct 2026
- Primary completion
- Sep 2029
01
Overview
A Phase 3 trial of cannabidiol in developmental and epileptic encephalopathy (DEE), sponsored by Jazz Pharmaceuticals plc. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
developmental and epileptic encephalopathy (DEE)
Beyond the preview
Go deeper on NCT07723976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07723976.